These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 32639313)

  • 1. Efficacy of a Novel Ophthalmic Antimicrobial Drug Combination Toward a Large Panel of Staphylococcus aureus Clinical Ocular Isolates From Around the World.
    Laskey E; Chen Y; Sohn MB; Gruber E; Chojnacki M; Wozniak RAF
    Cornea; 2020 Oct; 39(10):1278-1284. PubMed ID: 32639313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial Activity of a Triple Antibiotic Combination Toward Ocular Pseudomonas aeruginosa Clinical Isolates.
    Mei JA; Johnson W; Kinn B; Laskey E; Nolin L; Bhamare P; Stalker C; Dunman PM; Wozniak RAF
    Transl Vis Sci Technol; 2022 May; 11(5):26. PubMed ID: 35612831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a Broad-Spectrum Antimicrobial Combination for the Treatment of Staphylococcus aureus and Pseudomonas aeruginosa Corneal Infections.
    Chojnacki M; Philbrick A; Wucher B; Reed JN; Tomaras A; Dunman PM; Wozniak RAF
    Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30420484
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy of a Novel Antibiotic Drug Combination Toward Multidrug-Resistant Ocular Pathogens.
    Gowtham L; Wozniak RAF; Dunman PM; Sheba E; Garg P; Joseph J
    Cornea; 2024 Aug; 43(8):1044-1048. PubMed ID: 38537125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Novel, Broad-Spectrum Antimicrobial Combination for the Treatment of Pseudomonas aeruginosa Corneal Infections.
    Chojnacki M; Philbrick A; Scherzi T; Pecora N; Dunman PM; Wozniak RAF
    Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31332071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotic Resistance Among Ocular Pathogens in the United States: Five-Year Results From the Antibiotic Resistance Monitoring in Ocular Microorganisms (ARMOR) Surveillance Study.
    Asbell PA; Sanfilippo CM; Pillar CM; DeCory HH; Sahm DF; Morris TW
    JAMA Ophthalmol; 2015 Dec; 133(12):1445-54. PubMed ID: 26502312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotic resistance among bacterial conjunctival pathogens collected in the Antibiotic Resistance Monitoring in Ocular Microorganisms (ARMOR) surveillance study.
    Asbell PA; DeCory HH
    PLoS One; 2018; 13(10):e0205814. PubMed ID: 30335799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotic Resistance in the Treatment of Staphylococcus aureus Keratitis: a 20-Year Review.
    Chang VS; Dhaliwal DK; Raju L; Kowalski RP
    Cornea; 2015 Jun; 34(6):698-703. PubMed ID: 25811722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of antimicrobial susceptibility patterns in Staphylococcus aureus strains recovered from patients at two main health facilities in Kabul, Afghanistan.
    Naimi HM; Rasekh H; Noori AZ; Bahaduri MA
    BMC Infect Dis; 2017 Nov; 17(1):737. PubMed ID: 29187146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial resistance profile of methicillin-resistant
    Wu X; Wang C; He L; Xu H; Jing C; Chen Y; Lin A; Deng J; Cao Q; Deng H; Cai H; Chen Y; Yang J; Zhang T; Huang Y; Hao J; Yu H
    Front Cell Infect Microbiol; 2023; 13():1102779. PubMed ID: 36743309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surveillance of the Activity of Aminoglycosides and Fluoroquinolones Against Ophthalmic Pathogens from Europe in 2010-2011.
    Sanfilippo CM; Morrissey I; Janes R; Morris TW
    Curr Eye Res; 2016 May; 41(5):581-9. PubMed ID: 26200173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical resistance of Staphylococcus keratitis to ciprofloxacin monotherapy.
    Sharma V; Sharma S; Garg P; Rao GN
    Indian J Ophthalmol; 2004 Dec; 52(4):287-92. PubMed ID: 15693319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial resistance of Staphylococcus aureus isolated from skin infections and its implications in various clinical conditions in Korea.
    Baek YS; Jeon J; Ahn JW; Song HJ
    Int J Dermatol; 2016 Apr; 55(4):e191-7. PubMed ID: 26892888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ocular TRUST: nationwide antimicrobial susceptibility patterns in ocular isolates.
    Asbell PA; Colby KA; Deng S; McDonnell P; Meisler DM; Raizman MB; Sheppard JD; Sahm DF
    Am J Ophthalmol; 2008 Jun; 145(6):951-958. PubMed ID: 18374299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Susceptibility of drug-resistant staphylococci isolated from different parts of the ocular anterior segment to common ophthalmic antibiotics].
    Yue J; Wang CM; Lyu JX; Jian SJ; Niu YY; Liu SS; Sun ST; Han L; Zhang HM
    Zhonghua Yan Ke Za Zhi; 2022 Aug; 58(8):598-605. PubMed ID: 35959604
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro activities of 18 antimicrobial agents against Staphylococcus aureus isolates from the Institut Pasteur of Madagascar.
    Randrianirina F; Soares JL; Ratsima E; Carod JF; Combe P; Grosjean P; Richard V; Talarmin A
    Ann Clin Microbiol Antimicrob; 2007 May; 6():5. PubMed ID: 17521424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An in vitro resistance study of levofloxacin, ciprofloxacin, and ofloxacin using keratitis isolates of Staphylococcus aureus and Pseudomonas aeruginosa.
    Kowalski RP; Pandya AN; Karenchak LM; Romanowski EG; Husted RC; Ritterband DC; Shah MK; Gordon YJ
    Ophthalmology; 2001 Oct; 108(10):1826-9. PubMed ID: 11581056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of mupirocin and polymyxin B in experimental Staphylococcus aureus, Pseudomonas aeruginosa, and Serratia marcescens keratitis.
    Moreau JM; Conerly LL; Hume EB; Dajcs JJ; Girgis DO; Cannon BM; Thibodeaux BA; Stroman DW; O'Callaghan RJ
    Cornea; 2002 Nov; 21(8):807-11. PubMed ID: 12410042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and Molecular Epidemiology of an Emerging Panton-Valentine Leukocidin-Positive ST5 Methicillin-Resistant Staphylococcus aureus Clone in Northern Australia.
    McGuinness SL; Holt DC; Harris TM; Wright C; Baird R; Giffard PM; Bowen AC; Tong SYC
    mSphere; 2021 Feb; 6(1):. PubMed ID: 33568451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Moxifloxacin plus rifampin as an alternative for levofloxacin plus rifampin in the treatment of a prosthetic joint infection with Staphylococcus aureus.
    Wouthuyzen-Bakker M; Tornero E; Morata L; Nannan Panday PV; Jutte PC; Bori G; Kampinga GA; Soriano A
    Int J Antimicrob Agents; 2018 Jan; 51(1):38-42. PubMed ID: 28668678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.